HealthEquity: Compounding Flywheel Reveals Attractive Entry Point
HealthEquity, Inc. is positioned as a leading HSA administrator, capitalizing on rising healthcare costs and favorable legislative changes. The company reported a 9% revenue growth in FY2026, reaching $1.313 billion, with notable margin expansion and a 17% increase in custodial revenue. Management anticipates continued yield increases in FY2027, reinforcing its positive outlook.
- ▪HealthEquity is rated a Buy with a price target of $115.
- ▪The company experienced a 9% revenue growth in FY2026, totaling $1.313 billion.
- ▪Custodial revenue grew by 17% due to improved rate migration.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4908058-healthequity-compounding-flywheel-reveals-attractive-entry-point"},"author":{"@type":"Person","name":"Brock…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
